Activity

Treatment duration should be individualized by the treating physicians. Certain parameters mentioned above can be taken as warning signals of patients ending up as partial responders and hence the need of a prolonged extension phase.

Treatment duration should be individualized by the treating physicians. Certain parameters mentioned above can be taken as warning signals of patients ending up as partial responders and hence the need of a prolonged extension phase.

The relationship between the incidence of intestinal tuberculosis (TB) and Crohn’s disease (CD) is interesting, especially considering the striking similarity between the two conditions. Some studies from Asian populations suggested that the incidence of intestinal TB decreases when there is an increase in CD.

To compare the incidence trend between intestinal TB and CD over 15 years.

Medical records of patients seen in the Division of Gastroenterology over 15 years (2005-2019) were reviewed. CD was diagnosed according to the Copenhagen criteria. Intestinal TB was diagnosed in the appropriate clinical situation if any one or more of the following was present (1) positive TB MGIT culture; (2) positive Gene Xpert for TB; (3)suggestive histologic findings, with positive tissue acid-fast bacillus (AFB) on smear or with sustained response to anti-TB therapy. The incidence time trend of patients with CD and intestinal TB diagnosis was then studied year-wise.

632 medical case records were accessed; 60 patients were excluded due to inadequate data or not fulfilling diagnostic criteria. The 572 patients included 224 with intestinal TB (median age 37 years, IQR 22; 125 [56%] females) and 348 with CD (median age 40 years, IQR 25; 159 [46%] females [p<0.02 as compared to TB]). Thus, more patients with CD were seen during the study period, but there was no correlation between the incidence of the two conditions (r=0.318; p=0.25).

In Indian patients in a single private-sector center, there was no inverse correlation between the incidence of intestinal TB and CD over 15 years.

In Indian patients in a single private-sector center, there was no inverse correlation between the incidence of intestinal TB and CD over 15 years.

In most of the pleural effusion, fluid analysis generally gives the etiological diagnosis but in almost 20% it remains unclear. This study was designed to determine the diagnostic yield of a pleural biopsy using semi rigid thoracoscope and its complication rates.

This was a retrospective observational study conducted in the Department of Pulmonary Medicine, AIIMS Patna. All the patients diagnosed as unexplained pleural effusion between Jan 2018 and December 2019 were included in the study.

Total 76 out of 97 patients with unexplained exudative pleural effusion underwent medical thoracoscopy in the given period of 2 years. The mean age of the patients was 57.63 years. There were 46 males and 30 females. 38 patients (50%) had right-sided pleural effusion. More than half (52.6%) of study patients were on Anti-tubercular treatment in which only 11.84% had tuberculosis. In both unilateral and bilateral pleural effusion, the proportions of small, moderate, and large size of pleural effusions were 10.52, 42.10th unilateral and bilateral pleural effusion, the proportions of small, moderate, and large size of pleural effusions were 10.52, 42.10, and 47.36%, respectively. Thoracoscopy yielded a definitive diagnosis in 66 out of 76 patients (86.84%), and in 10 patients (13.15%), biopsy was inconclusive. Of 76 patients, malignancy was confirmed in 58 (76.31%), and tuberculosis in 8 (11.84%) patients CONCLUSION This study concludes that, medical thoracoscopy with semi-rigid thoracoscope is an invaluable tool in the diagnosis of patients with unexplained exudative pleural effusion. Selleck ML264 It is a very simple and safe method with high diagnostic yield and associated with few complications. Malignancy was found to be the most common cause of unexplained exudative pleural effusion.

Tuberculosis remains a major public health problem in various parts of the world. It leads to various haematological changes. Study of these haematological changes will help better patient management.

It is to evaluate haematological changes in tuberculosis patients and compare the result with special emphasis to bone marrow changes as active case search is sharply decreasing the miliary tuberculosis. It is also to evaluate the patients with before and after the Intensive Phase of Anti Koch Treatment. Sputum positive and sputum negative tuberculosis patients confirmed by other ancillary techniques were included into this study. It is conducted at a tertiary level hospital in rural area.

In this study bone marrow hypercellularity was of erythroid series with only 1.92% patients showed granuloma in bone marrow aspiration. In addition to bone marrow changes, significant changes were evident in haemoglobin level, Erythrocyte Sedimentation Rate (ESR) Total White Blood Cell count and RBC count.

In majority showed, ESR level may be considered as prognostic parameters of tuberculosis.

The current study has evaluated the MICs and MBCs of ZnONPs, MgONPs, and MgONPs-ZnONPs against H

Rv Mtb and MDR-Mtb.

Mixture, magnesium oxide nanoparticles (NPs) and zinc oxide (MgONPs-ZnONPs) were prepared. The microplate alamar blue (MABA) assay and the proportion method were used to evaluate of anti-tubercular activity against MDR-MTB. MTT test was done to MgONPs-ZnONPs against Vero and HepG

cell lines.

The MIC of MgONPs and ZnONPs were 0.195 and 0.468μgmL

against 10

of H

Rv Mtb. As well, 0.166μgmL

of MgONPs-ZnONPs was able to inhibit 10

H

Rv Mtb. The MIC of MgONPs against 10

concentrations of MDR-Mtb was 12.5μgmL

. The MIC of MgONPs/ZnONPs against 10

concentrations of MDR-Mtb reached to 0.664μgmL

. The MBC value of ZnONPs increased to 1.875μgmL

against 10

concentrations of MDR-Mtb. Testing showed that the MBCs of MgONPs/ZnONPs reached to 1.328μgmL

against 10

concentrations of MDR-Mtb. The IC

against MDR-TB was 0.779μgmL

for ZnONPs and 0.883μgmL

for MgONPs-ZnONPs. The MgONPs-ZnONPs was not toxic to Vero cell lines however ZnONPs could inhibit the Vero and HepG

cell lines.